RET and hereditary pheochromocytoma-paraganglioma: Among these, the c.1858T>C (p.C620R) variant is notable, with a reported 13% penetrance for HD and a 20-30% risk for developing pheochromocytoma (PHEO; OMIM#171300) in MEN2A patients [7-10].